Skip to content

Evaluation of the effect of Glycerin suppository on anal fissure healing

Evaluation of the effect of Glycerin suppository application in patients with Chronic anal fissure

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210717051915N1
Enrollment
120
Registered
2021-07-31
Start date
2021-09-23
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic anal fissure. Chronic anal fissure

Interventions

Intervention 1: Intervention group: treatment is in the form of pediatric glycerin suppository 1 g, 5 minutes after using lidocaine ointment and diltiazem every morning, and the use of lidocaine and
Some lubricant gel can be impregnated around the suppository to facilitate passage. Iran Najo Pharmaceutical Co. Tehran-Iran. Intervention 2: Control group: Treatment of fissure in thi

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Posterior or anterior fissure No previous history of autoimmune disease No history of immunodeficiency disease No history of previous gastrointestinal cancer People over 40 years of age with normal colonoscopy No risk factor including weight loss during 6 Last month No anorexia No history of gastrointestinal genetic cancers (such as FAP, HNPCC) If a person is positive with FIT or a person with iron deficiency anemia, if he has a normal colonoscopy and endoscopy can be included in the study

Exclusion criteria

Exclusion criteria: Reluctance to continue treatment smoking and spicy spices

Design outcomes

Primary

MeasureTime frame
1) Patients' pain score 2) Percentage of constipation improvement in the intervention group 3) Percentage of bleeding improvement in the intervention group 4) Percentage of improvement of incomplete stool discharge in the intervention group 5) Percentage of burning sensation in the intervention group 6) Percentage of itching improvement in the intervention group. Timepoint: 1) Pain score of the intervention group with the control group before and after treatment (first day, second weekend, fourth weekend) 2) constipation of the intervention group and control group (first day, second weekend, fourth weekend) 3) bleeding Intervention group and control group (first day, second weekend, fourth weekend) 4) incomplete defecation of the intervention group and control group (first day, second weekend, fourth weekend) 5) burning of the intervention group and control group (first day , Second weekend, fourth weekend) 6) itching Intervention and control group (first day, second weekend, fourth weekend). Method of measurement: 1) Measuring pain through Visual Analogue Scale 2) Percentage of improvement of constipation through checklist 3) Percentage of improvement of bleeding through checklist 4) Percentage of improvement of incomplete stool discharge through checklist

Secondary

MeasureTime frame
1) Headache improvement 2) Quality of life indicators score. Timepoint: 1) Improvement of headache after treatment (second weekend, fourth weekend) 2) score of quality of life indicators before and after treatment (first day, second weekend, fourth weekend). Method of measurement: 1) Improvement of headache through a checklist 2) Score of quality of life indicators based on WHO-QOL 100 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Eslamin

Esfahan University of Medical Sciences

mr.esl67@gmail.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026